Alison Yoder, MD MPH

Peer-Reviewed Articles

1. Devireddy A, Yi Y, Nordlund KN, Lin R, Salem A, Yang NX, Keatts S, Jerez O, Farooqi A, Bishop AJ, Guadagnolo BA, Nagarajan P, Weiser R, Fisher SB, Goepfert R, Ross MI, Amaria RN, Oliva ICG, Yoder AK, Mitra D. The Role of Adjuvant Primary Site Radiotherapy for Cutaneous Melanoma Patients with Microsatellitosis. Ann Surg Oncol 33(8):7461-7470, 2026. e-Pub 2026. PMID: 42189441.
2. Devireddy A, Yi Y, Nordlund KN, Lin R, Salem A, Yang NX, Keatts S, Jerez O, Farooqi A, Bishop AJ, Ashleigh Guadagnolo B, Nagarajan P, Weiser R, Fisher SB, Goepfert R, Ross MI, Amaria RN, Glitza Oliva IC, Yoder AK, Mitra D. ASO Visual Abstract: The Role of Adjuvant Primary Site Radiotherapy for Patients with Cutaneous Melanoma with Microsatellitosis. Ann Surg Oncol 33(8):7481-7482, 2026. e-Pub 2026. PMID: 42223772.
3. Fis-Loperena M, Kouzy R, Thomas RJ, Cha EE, Manzar GS, Paulino AC, Yoder AK. Radiation Therapy Documentation Deficiencies in Cancer Survivorship Documents. Pract Radiat Oncol, 2026. e-Pub 2026. PMID: 42092691.
4. Arifin AJ, Bishop AJ, Mitra D, Yoder A, Araujo DM, Haddad EFN, Ratan R, Livingston JA, Lewis VO, Lin PP, Moon BS, Keung EZ, Roland CL, Scally CP, Mericli AF, Guadagnolo BA, Farooqi AS. Outcomes Following Combined Modality Treatment to the Primary Site in Select Patients With Metastatic Soft Tissue Sarcoma. Pract Radiat Oncol 16(2):169-175, 2026. e-Pub 2026. PMID: 41579133.
5. Yang NX, Rosamilia GL, Arifin AJ, Salem AF, Yoder AK, Keatts SA, Jerez O, Lin R, Bishop AJ, Farooqi AS, Weiser R, Ross MI, Mericli AF, Guadagnolo BA, Goepfert RP, Mitra D. Surgical Reconstruction Toxicity Following Hypofractionated Adjuvant Radiation Therapy for Primary Cutaneous Melanoma. Pract Radiat Oncol 16(2):e71-e77, 2026. e-Pub 2026. PMID: 41380909.
6. Yoder A, Netherton T, Wang X, Lim T, Wang C, Luo D, Wang C, Thrower S, Nguyen C, Lyu H, Scally C, Roland C, Mitra D, Bishop A, Farooqi A, Guadagnolo BA. The Impact of Radiation Dose to Bowel on the Risk of Developing Gastrointestinal Toxicities When Treating Abdominopelvic Soft-Tissue Sarcomas With Preoperative Radiation Therapy. Adv Radiat Oncol 11(2):101953, 2026. e-Pub 2026. PMID: 41492444.
7. Yoder AK, Thomas RJ, Huang A, Mandalapu A, Roque DM, Bowles K, Albuquerque K, Son C, Ludwig MS, Levinson K, Coghill AE, Chiao EY, Lin LL. Cervical Cancer Outcomes in Women With HIV in the Age of Antiretroviral Therapy. JAMA Netw Open 8(8), 2025. e-Pub 2025. PMID: 40815516.
8. Mandalapu AS, Yoder AK, Wang X, Mitra D, Bishop AJ, Guadagnolo BA, Farooqi AS. Excellent Response Following Palliative Radiation for Locally Advanced Epidemic/AIDS-Associated Kaposi Sarcoma of the Lower Extremity: A Case Report. Adv Radiat Oncol 10(8):101823, 2025. e-Pub 2025. PMID: 40686739.
9. Traweek RS, Zoghbi M, Lazcano R, Cope BM, Bishop AJ, Farooqi A, Mitra D, Yoder AK, Guadagnolo BA, Ingram DR, Wani K, Shamsutdinova D, Lazar AJ, Wang WL, Scally CP, Keung EZ, Torres KE, Hunt KK, Ratan R, Livingston JA, Nakazawa MS, Araujo DM, Patel S, Ravi V, Conley AP, Zarzour MA, Somaiah N, Roland CL, Nassif Haddad EF. Hyalinization-based pathologic response and immune infiltration following neoadjuvant radiotherapy with or without immune-checkpoint blockade in localized undifferentiated pleomorphic sarcoma. ESMO Open 10(7):105493, 2025. e-Pub 2025. PMID: 40561658.
10. Manzar GS, Dudzinski SO, Yoder AK, Seo A, Nasr LF, Rafei H, Becnel MR, Patel KK, Lee HC, Kaufman GP, Gaballa MM, Ye JC, Saini N, Thomas SK, Amini B, Orlowski RZ, Dabaja BS, Pinnix CC, Gunther JR, Wu SY, Fang PQ. Outcome of Patients With Central Nervous System Multiple Myeloma (CNS-MM) Treated With CNS-Directed Radiation Therapy. Clin Lymphoma Myeloma Leuk 25(4):271-284, 2025. e-Pub 2025. PMID: 39709251.
11. Manzar GS, Wu SY, Dudzinski SO, Cha EE, Yoder AK, Corrigan KL, Nasr LF, Sallard G, Ahmed S, Fayad LE, Chihara D, Nair R, Westin JR, Daher M, Neelapu SS, Nastoupil LJ, Gunther JR, Pinnix CC, Dabaja BS, Strati P, Fang PQ. Characterization of Lymphopenia and Correlating the Risk of Cytopenias With Dose and Bone Marrow Volume Irradiated in Aggressive B Cell Lymphoma Patients Bridged With Radiation Therapy for Chimeric Antigen Receptor-T Cell Therapy. Int J Radiat Oncol Biol Phys 121(4):1011-1025, 2025. e-Pub 2025. PMID: 39303997.
12. Abana CO, Carriere PP, Damen PJ, van Rossum PSN, Yoder AK, Bravo PL, Wei X, Pollard-Larkin JM, Nitsch PL, Murphy MB, Hofstetter WL, Liao Z, Lin SH. Comparative Outcomes and Toxicity in Patients With Esophageal Cancer After Trimodality Therapy With Step-and-Shoot Intensity-Modulated Radiation Therapy Versus Volumetric Modulated Arc Therapy: The MD Anderson Experience. Clin Oncol (R Coll Radiol) 38:103668, 2025. e-Pub 2025. PMID: 39706143.
13. Manzar, G, Pinnix, CC, Dudzinski, SO, Marqueen, KE, Cha, E, Nasr, L, Yoder, A, Rooney, MK, Strati, P, Ahmed, S, Nze, CC, Nair, R, Fayad, LE, Wang, L, Nastoupil, L, Westin, JR, Flowers, CR, Neelapu, SS, Gunther, J, Dabaja, BS, Wu, SY, Fang, PQ. Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomas. Frontiers in Immunology 16, 2025. e-Pub 2025. PMID: 39958356.
14. Torres MB, Leung CH, Zoghbi M, Lazcano R, Ingram D, Wani K, Keung EZ, Zarzour MA, Scally CP, Hunt KK, Conley A, Bishop AJ, Guadagnolo BA, Farooqi A, Mitra D, Yoder AK, Nakazawa MS, Araujo D, Livingston A, Ratan R, Patel S, Ravi V, Lazar AJ, Roland CL, Somaiah N, Nassif Haddad EF. Dedifferentiated liposarcomas treated with immune checkpoint blockade: the MD Anderson experience. Front Immunol 16:1567736, 2025. e-Pub 2025. PMID: 40370451.
15. Yoder AK, Farooqi A, Mitra D, Livingston JA, Araujo DM, Sturgis EM, Goepfert R, Bishop AJ, Guadagnolo BA. Outcomes for Patients With Head and Neck Sarcoma Treated Curatively With Radiation Therapy and Surgery. Pract Radiat Oncol 14(5):e373-e382, 2024. e-Pub 2024. PMID: 38851534.
16. Yoder AK, Xu T, Youssef P, DeSnyder S, Marqueen KE, Isales L, Lin R, Smith BD, Woodward WA, Stauder MC, Strom EA, Aldrich MB, Shaitelman SF. Association Between Symptom Burden and Early Lymphatic Abnormalities After Regional Nodal Irradiation for Breast Cancer. Pract Radiat Oncol 14(3):e180-e189, 2024. e-Pub 2024. PMID: 37914083.
17. Farooqi AS, Yoder AK, Lin HY, Pasalic D, Erasmus J, Betancourt S, Wernz C, Mitra D, Zarzour MA, Somaiah N, Conley A, Ratan R, Livingston A, Araujo DM, Roland C, Scally C, Keung E, Gandhi SN, Ashleigh Guadagnolo B, Nguyen QN, Bishop AJ. SABR for Sarcoma Lung Metastases: Indications for Treatment and Guidance for Patient Selection. Int J Radiat Oncol Biol Phys 118(4):971-978, 2024. e-Pub 2024. PMID: 37914142.
18. Yoder AK, Lakomy DS, Wu J, Andring LM, Corrigan KL, Fellman B, Jhingran A, Klopp AH, Colbert LE, Soliman PT, Frumovitz MM, Peterson SK, Lin LL. Comparing long-term sexual dysfunction across different uterine cancer treatment modalities. Brachytherapy 23(1):1-9, 2024. e-Pub 2024. PMID: 37914588.
19. Manzar GS, Cha EE, Corrigan KL, Yoder AK, Schrank BR, Nasr LF, Chihara D, Castillo LM, Nair R, Jain P, Neelapu SS, Rodriguez MA, Strati P, Nastoupil LJ, Gunther JR, Dabaja BS, Pinnix CC, Wu SY, Fang PQ. Outcomes and toxicities in patients with diffuse-large B cell lymphoma involving the gastrointestinal tract and digestive organs. Front Oncol 14:1447020, 2024. e-Pub 2024. PMID: 39324011.
20. Salzillo TC, Dresner MA, Way A, Wahid KA, McDonald BA, Mulder S, Naser MA, He R, Ding Y, Yoder A, Ahmed S, Corrigan KL, Manzar GS, Andring L, Pinnix C, Stafford RJ, Mohamed ASR, Christodouleas J, Wang J, Fuller CD. Development and implementation of optimized endogenous contrast sequences for delineation in adaptive radiotherapy on a 1.5T MR-linear-accelerator: a prospective R-IDEAL stage 0-2a quantitative/qualitative evaluation of in vivo site-specific quality-assurance using a 3D T2 fat-suppressed platform for head and neck cancer. J Med Imaging (Bellingham) 10(6):065501, 2023. e-Pub 2023. PMID: 37937259.
21. Andring LM, Abu-Gheida I, Bathala T, Yoder AK, Manzar GS, Maldonado JA, Frank SJ, Choi S, Nguyen QN, Hoffman K, McGuire SE, Mok H, Aparicio A, Chapin BF, Tang C. Definitive local therapy for T4 prostate cancer associated with improved local control and survival. BJU Int 132(3):307-313, 2023. e-Pub 2023. PMID: 37057728.
22. Yoder AK, Farooqi AS, Wernz C, Subramaniam A, Ravi V, Goepfert R, Sturgis EM, Mitra D, Bishop AJ, Guadagnolo BA. Outcomes after definitive treatment for cutaneous angiosarcomas of the face and scalp: Reevaluating the role of surgery and radiation therapy. Head Neck 45(8):1943-1951, 2023. e-Pub 2023. PMID: 37272774.
23. Yoder AK, Dong E, Yu X, Echeverria A, Sharma S, Montealegre J, Ludwig MS. Effect of Quality of Life on Radiation Adherence for Patients With Cervical Cancer in an Urban Safety Net Health System. Int J Radiat Oncol Biol Phys 116(1):182-190, 2023. e-Pub 2023. PMID: 36228745.
24. Yoder AK, Lakomy DS, Wu J, Andring LM, Fellman B, Colbert LE, Jhingran A, Klopp AH, Soliman P, Peterson SK, Lin LL. Impact of Treatment Modality on Quality of Life Among Uterine Cancer Survivors. Clin Oncol (R Coll Radiol) 35(2):e215-e226, 2023. e-Pub 2023. PMID: 36494250.
25. Lakomy DS, Yoder AK, Wu J, Hernandez M, Ayoola-Adeola M, Jhingran A, Klopp A, Soliman P, Peterson SK, Lin LL. Impact of treatment modality on pelvic floor dysfunction among uterine cancer survivors. Int J Gynecol Cancer, 2022. e-Pub 2022. PMID: 35680139.
26. Shi F, Yoder AK, Mach C, Dalwadi S, Anderson ML, Hall TR, Ludwig MS. Impact of hematologic toxicities during concurrent chemoradiation for cervical cancer. Obstet Gynecol Sci 65(2):176-187, 2022. e-Pub 2022. PMID: 35189679.
27. Corrigan KL, Yoder A, De B, Lin L, Jhingran A, Joyner MM, Eifel PJ, Colbert LE, Lu KH, Klopp AH. Long-term survival following definitive radiation therapy for recurrence or oligometastases in gynecological malignancies: A landmark analysis. Gynecol Oncol 164(3):550-557, 2022. e-Pub 2022. PMID: 34974906.
28. Andring L, Yoder A, Pezzi T, Tang C, Kumar R, Mahmood U, Walker GV. PSA: Declining utilization of prostate brachytherapy. Brachytherapy 21(1):6-11, 2022. e-Pub 2022. PMID: 34420862.
29. Yoder AK, Lakomy DS, Dong Y, Raychaudhury S, Royse K, Hartman C, Richardson P, White DL, Kramer JR, Lin LL, Chiao E. The association between protease inhibitors and anal cancer outcomes in veterans living with HIV treated with definitive chemoradiation: a retrospective study. BMC Cancer 21(1):776, 2021. e-Pub 2021. PMID: 34225709.
30. Boyce-Fappiano D, Bedrosian I, Shen Y, Lin H, Gjyshi O, Yoder A, Shaitelman SF, Woodward WA. Evaluation of overall survival and barriers to surgery for patients with breast cancer treated without surgery: a National Cancer Database analysis. NPJ Breast Cancer 7(1):87, 2021. e-Pub 2021. PMID: 34226566.
31. Elhammali A, Milgrom SA, Amini B, Gunther JR, Yoder A, Ludmir EB, Moon B, Weber DM, Thomas SK, Garg N, Manasanch EE, Patel KK, Orlowski RZ, Lee HC, Bird JE, Satcher R, Lin P, Pinnix CC, Dabaja BS. Postoperative Radiotherapy for Multiple Myeloma of Long Bones: Should the Entire Rod Be Treated?. Clin Lymphoma Myeloma Leuk 19(8):e465-e469, 2019. e-Pub 2019. PMID: 31133526.
32. Elhammali A, Blanchard P, Yoder A, Liao Z, Zhang X, Ronald Zhu X, Allen PK, Jeter M, Welsh J, Nguyen QN. Clinical outcomes after intensity-modulated proton therapy with concurrent chemotherapy for inoperable non-small cell lung cancer. Radiother Oncol 136:136-142, 2019. e-Pub 2019. PMID: 31015115.
33. Yoder AK, Gunther JR, Milgrom SA, Pham M, Hancock D, McSpadden K, Garcia J, Mirkovic D, Dabaja BS, Pinnix CC. Rainbow IMRT and Volumetric Imaging for Anterior Mesenteric Targets. Pract Radiat Oncol 9(3):147-152, 2019. e-Pub 2019. PMID: 30708131.
34. Hanania AN, Myers P, Yoder AK, Bulut A, Henry Yu Z, Eraj S, Bowers J, Bonnen MD, Echeverria A, Hall TR, Anderson ML, Ludwig M. Inversely and adaptively planned interstitial brachytherapy: A single implant approach. Gynecol Oncol 152(2):353-360, 2019. e-Pub 2019. PMID: 30449720.
35. Yoder AK, Gunther JR, Milgrom SA, Mirkovic D, Nastoupil L, Neelapu S, Fanale M, Fowler N, Westin J, Lee HJ, Rodriguez MA, Iyer SP, Fayad L, Nieto YL, Hosing C, Ahmed S, Medeiros LJ, Khoury JD, Garg N, Amini B, Dabaja BS, Pinnix CC. Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery With Volumetric Image-guided Intensity Modulated Radiation Therapy. Clin Lymphoma Myeloma Leuk 19(1):e51-e61, 2019. e-Pub 2019. PMID: 30360985.
36. Waheed NL, Yoder AK, Van Wyhe RD, Carpenter SL. Stereotactic Body Radiation Therapy for Prostate Cancer: An Institutional Experience Using MRI-guided Treatment Planning. Cureus 10(5):e2590, 2018. e-Pub 2018. PMID: 30009104.

Abstracts

1. Yang NX, Arifin AJ, Salem Jr AFM, Yoder AK, Keatts S, Jerez O, Lin R, Bishop AJ, Farooqi A, Goepfert RP, Weiser R, Ross MI, Guadagnolo BA, Mericli A, Mitra D. Surgical Graft and Flap Toxicity Following Hypofractionated Adjuvant Radiotherapy for Primary Cutaneous Melanoma. Int J Radiat Oncol Biol Phys 123(1):S71-S72, 2025. e-Pub 2025.
2. Yoder A, Salem Jr AFM, Nordlund K, Lin R, Shaitelman SF, Fuller CD, Lee A, Goodman CR, Guadagnolo BA, Bishop AJ, Farooqi A, Mitra D. Evaluating the Relationship of Baseline Skin Pigmentation Phenotype on the Evolution of Radiation Dermatitis. Int J Radiat Oncol Biol Phys 123(1):S64-S65, 2025. e-Pub 2025.
3. Nordlund K, Devireddy A, Lin R, Salem Jr AFM, Yang NX, Keatts S, Farooqi A, Bishop AJ, Guadagnolo BA, Weiser R, Fisher S, Goepfert RP, Ross MI, Amaria R, McQuade J, Glitza I, Yoder AK, Mitra D. The Role of Adjuvant Primary Site Radiotherapy for Patients with Cutaneous Melanoma Microsatellitosis. Int J Radiat Oncol Biol Phys 123(1):S70, 2025. e-Pub 2025.
4. Kanala TS, Yoder AK, Mitra D, Bishop AJ, Hooda Z, Araujo A, Ratan R, Somaiah N, Haddad Nassif EF, Mitchell KG, Rajaram R, Vaporciyan AA, Rice DC, Guadagnolo BA, Farooqi A. Outcomes for Patients with Localized Intrathoracic Soft Tissue Sarcomas Treated with Surgery and Radiation Therapy. Int J Radiat Oncol Biol Phys 123(1):e54-e55, 2025. e-Pub 2025.
5. Arifin A, Jerez O, Keatts S, Salem AFM, Farooqi A, Bishop AJ, Yoder AK, Goepfert RP, Weiser R, Amaria R, McQuade J, Ross MI, Guadagnolo BA, Mitra D. Adjuvant Primary Site Radiation Therapy for Melanoma in the Immunotherapy Era. Int J Radiat Oncol Biol Phys 120(2):S179-180, 2024. e-Pub 2024.

Book Chapters

1. Yoder AK, Bishop AJ, Guadagnolo BA. Soft Tissue Sarcoma. In: Pocket Radiation Oncology. 2nd. Wolters Kluwer, 2024.
2. Yoder AK, Mitra D, Guadagnolo BA. Melanoma. In: Pocket Radiation Oncology. 2nd. Wolters Kluwer, 2024.
3. Yoder AK, Mitra D, Guadagnolo BA. Non-Melanoma Skin Cancer. In: Pocket Radiation Oncology. 2nd. Wolters Kluwer, 2024.
4. Yoder AK, Mitra D, Bishop AJ, Guadagnolo BA. Merkel Cell Carcinoma. In: Pocket Radiation Oncology. 2nd. Wolters Kluwer, 2024.
5. Yoder AK, Ning M, Lin LL. Cancer Radiotherapy – General Considerations and Human Biology. In: Locoregional Radionuclide Cancer Therapy. Springer, 2022.
6. Yoder AK. Supranuclear Disorders of Gaze. In: Clinical Pathways in Neuro-Ophthalmology. 3rd. Thieme, 2018.

Letters to the Editor

1. Elhammali A, Amini B, Ludmir EB, Gunther JR, Milgrom SA, Pinnix CC, Andraos T, Yoder A, Weber D, Orlowski R, Manasanch E, Patel K, Strati P, Nair R, Lee HC, Thomas S, Iyer S, Kaufmann G, Garg N, Dabaja BS. New paradigm for radiation in multiple myeloma: lower yet effective dose to avoid radiation toxicity. Haematologica 105: e355-e357, 2020.